|Ticker||Status||Jurisdiction||Filing Date||CP Start||CP End||CP Loss||Deadline|
|Ticker||Case Name||Status||CP Start||CP End||Deadline||Settlement Amt|
|Ticker||Name||Date||Analyst Firm||Up/Down||Target ($)||Rating Change||Rating Current|
Enanta Pharma (NASDAQ:ENTA) reported its Q4 earnings results on Monday, November 20, 2023 at 04:01 PM.
Here's what investors need to know about the announcement.
Enanta Pharma beat estimated earnings by 33.5%, reporting an EPS of $-1.33 versus an estimate of $-2.0.
Revenue was down $1.39 million from the same period last year.
Last quarter the company beat on EPS by $0.47 which was followed by a 4.24% drop in the share price the next day.
Here's a look at Enanta Pharma's past performance:
|Quarter||Q3 2023||Q2 2023||Q1 2023||Q4 2022|
To track all earnings releases for Enanta Pharma visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: ENTA